In‐hospital prevalence of mucormycosis among coronavirus disease 2019 (COVID‐19) patients and COVID‐19 in mucormycosis: a systematic review and meta‐analysis

International Forum of Allergy & RhinologyVolume 12, Issue 3 p. 313-317 RESEARCH NOTE In-hospital prevalence of mucormycosis among coronavirus disease 2019 (COVID-19) patients and COVID-19 in mucormycosis: a systematic review and meta-analysis Akansha Sinha BMed, Akansha Sinha BMed University of New South Wales (UNSW), South Western Sydney Clinical School, Liverpool, NSW, Australia Neurovascular Imaging Laboratory, Clinical Sciences Stream, Ingham Institute for Applied Medical Research, Sydney, NSW, AustraliaSearch for more papers by this authorSonu Menachem Maimonides Bhaskar MD, PhD, Corresponding Author Sonu Menachem Maimonides Bhaskar MD, PhD [email protected] [email protected] orcid.org/0000-0002-9783-3628 University of New South Wales (UNSW), South Western Sydney Clinical School, Liverpool, NSW, Australia Neurovascular Imaging Laboratory, Clinical Sciences Stream, Ingham Institute for Applied Medical Research, Sydney, NSW, Australia NSW Brain Clot Bank, NSW Health Pathology, Sydney, NSW, Australia Department of Neurology and Neurophysiology, Liverpool Hospital and South Western Sydney Local Health District, Sydney, NSW, Australia Correspondence Sonu M.M. Bhaskar, MD, PhD, Department of Neurology & Neurophysiology, Neurophysiology Level 1, Clinical Sciences Building, Elizabeth St, Liverpool Hospital, Liverpool, NSW 2170, Australia. Email: [email protected]: [email protected]Search for more papers by this author Akansha Sinha BMed, Akansha Sinha BMed University of New South Wales (UNSW), South Western Sydney Clinical School, Liverpool, NSW, Australia Neurovascular Imaging Laboratory, Clinical Sciences Stream, Ingham Institute for Applied Medical Research, Sydney, NSW, AustraliaSearch for more papers by this authorSonu Menachem Maimonides Bhaskar MD, PhD, Corresponding Author Sonu Menachem Maimonides Bhaskar MD, PhD [email protected] [email protected] orcid.org/0000-0002-9783-3628 University of New South Wales (UNSW), South Western Sydney Clinical School, Liverpool, NSW, Australia Neurovascular Imaging Laboratory, Clinical Sciences Stream, Ingham Institute for Applied Medical Research, Sydney, NSW, Australia NSW Brain Clot Bank, NSW Health Pathology, Sydney, NSW, Australia Department of Neurology and Neurophysiology, Liverpool Hospital and South Western Sydney Local Health District, Sydney, NSW, Australia Correspondence Sonu M.M. Bhaskar, MD, PhD, Department of Neurology & Neurophysiology, Neurophysiology Level 1, Clinical Sciences Building, Elizabeth St, Liverpool Hospital, Liverpool, NSW 2170, Australia. Email: [email protected]: [email protected]Search for more papers by this author First published: 11 October 2021 https://doi.org/10.1002/alr.22906Citations: 6 Funding information: This work was funded by the NSW Ministry of Health (2019-2022) to Sonu M.M. Bhaskar. Read the full textAboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onEmailFacebookTwitterLinkedInRedditWechat CONFLICT OF INTEREST The authors declare that they have no conflict of interest. Open Research DATA AVAILABILITY STATEMENT The original contributions presented in the study are included in the article and Supporting Information; further inquiries can be directed to the corresponding author. Supporting Information Filename Description alr22906-sup-0001-SuppMat.pdf496.6 KB Supporting Material Please note: The publisher is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article. REFERENCES 1Jose A, Singh S, Roychoudhury A, Kholakiya Y, Arya S, Roychoudhury S. Current understanding in the pathophysiology of SARS-CoV-2-associated rhino-orbito-cerebral mucormycosis: a comprehensive review. J Maxillofac Oral Surg. 2021; 20(3): 373–380. https://doi.org/10.1007/s12663-021-01604-2 10.1007/s12663-021-01604-2 PubMedWeb of Science®Google Scholar 2Singh AK, Singh R, Joshi SR, Misra A. Mucormycosis in COVID-19: a systematic review of cases reported worldwide and in India. Diabetes Metab Syndr. 2021; 15(4):102146. https://doi.org/10.1016/j.dsx.2021.05.019 10.1016/j.dsx.2021.05.019 CASPubMedWeb of Science®Google Scholar 3Bhattacharyya A, Sarma P, Sharma DJ, et al. Rhino-orbital-cerebral-mucormycosis in COVID-19: a systematic review. Indian J Pharmacol. 2021; 53(4): 317–327. https://doi.org/10.4103/ijp.ijp_419_21 CASPubMedWeb of Science®Google Scholar 4Moorthy A, Gaikwad R, Krishna S, et al. SARS-CoV-2, uncontrolled diabetes and corticosteroids-an unholy trinity in invasive fungal infections of the maxillofacial region? a retrospective, multi-centric analysis. J Maxillofac Oral Surg. 2021; 20(3): 1–8. https://doi.org/10.1007/s12663-021-01532-1 10.1007/s12663-021-01532-1 PubMedWeb of Science®Google Scholar 5Bayram N, Ozsaygili C, Sav H, et al. Susceptibility of severe COVID-19 patients to rhino-orbital mucormycosis fungal infection in different clinical manifestations. Jpn J Ophthalmol. 2021; 65(4): 515–525. https://doi.org/10.1007/s10384-021-00845-5 10.1007/s10384-021-00845-5 CASPubMedWeb of Science®Google Scholar 6Prakash H, Ghosh AK, Rudramurthy SM, et al. A prospective multicenter study on mucormycosis in India: epidemiology, diagnosis, and treatment. Med Mycol. 2019; 57(4): 395–402. https://doi.org/10.1093/mmy/myy060 10.1093/mmy/myy060 PubMedWeb of Science®Google Scholar 7Stone N, Gupta N, Schwartz I. Mucormycosis: time to address this deadly fungal infection. Lancet Microbe. 2021; 2(8): e343–e344. https://doi.org/10.1016/s2666-5247 10.1016/S2666-5247(21)00148-8 Google Scholar 8Tandon N, Anjana RM, Mohan V, et al. The increasing burden of diabetes and variations among the states of India: the Global Burden of Disease Study 1990–2016. Lancet Glob Health. 2018; 6(12): e1352–e1362. https://doi.org/10.1016/s2214-109x 10.1016/S2214-109X(18)30387-5 PubMedWeb of Science®Google Scholar 9Chakrabarti A, Das A, Sharma A, et al. Ten years' experience in zygomycosis at a tertiary care centre in India. J Infect. 2001; 42(4): 261–266. https://doi.org/10.1053/jinf.2001.0831 10.1053/jinf.2001.0831 CASPubMedWeb of Science®Google Scholar 10Bala K, Chander J, Handa U, Punia RS, Attri AK. A prospective study of mucormycosis in north India: experience from a tertiary care hospital. Med Mycol. 2015; 53(3): 248–257. https://doi.org/10.1093/mmy/myu086 10.1093/mmy/myu086 PubMedWeb of Science®Google Scholar Citing Literature Volume12, Issue3March 2022Pages 313-317 ReferencesRelatedInformation